Kopran is trading -1.61% lower at Rs 183.50 as compared to its last closing price. Kopran has been trading in the price range of 188.95 & 181.00. Kopran has given -15.77% in this year & -3.17% in the last 5 days. Kopran has TTM P/E ratio 24.97 as compared to the sector P/E of 28.67.The company posted a net profit of 7.38 Crores in its last quarter.Listed peers of Kopran include Shukra Pharmaceuticals (-1.99%), Bharat Parenterals (1.79%), Kopran (-1.61%).The Mutual Fund holding in Kopran was at 0.94% in 31 Mar 2024. The MF holding has increased from the last quarter. The FII holding in Kopran was at 0.86% in 31 Dec 2024. The FII holding has decreased from the last quarter.
Updated on Feb 09, 2025, 03:27 PM UTC
|
|
|
|
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
---|---|---|---|---|---|---|---|---|
Shukra Pharmaceuticals | Bullish | 219.65 | -1.99 | 961.80 | 56.23 | 18.08 | 0.42 | 4.61 |
Bharat Parenterals | Moderately Bearish | 1,324.00 | 1.79 | 912.50 | 51.76 | 3.82 | 0.08 | 37.09 |
Kopran | Bearish | 183.50 | -1.61 | 877.38 | 16.88 | 1.75 | 1.68 | 3.38 |
Kwality Pharmaceuticals | Moderately Bearish | 809.00 | 2.24 | 839.43 | 28.26 | 3.68 | - | 8.72 |
Nectar Lifesciences | Neutral | 36.80 | 4.13 | 842.24 | 162.80 | 0.76 | - | 13.12 |
Meeting Date | Purpose |
---|---|
2025-02-11 | Quarterly Results |
2024-11-13 | Quarterly Results |
2024-08-08 | Quarterly Results |
2024-05-16 | Audited Results & Final Dividend |
2024-02-07 | Quarterly Results |
Kopran is trading at 183.50 as on Fri Feb 07 2025 09:54:12. This is -1.61% lower as compared to its previous closing price of 186.50.
The market capitalization of Kopran is 877.38 Cr as on Fri Feb 07 2025 09:54:12.
The 52 wk high for Kopran is 369.20 whereas the 52 wk low is 174.40
Kopran can be analyzed on the following key metrics -
Kopran reported a net profit of 50.96 Cr in 2024.
The Mutual Fund Shareholding was 0.94% at the end of 31 Mar 2024.